Lung Disease: Clinical Trials & Testing

Getting patients for clinical lung disease or disorder trials like asthma, COPD, cystic fibrosis, lower respiratory infections, or idiopathic pulmonary fibrosis (IPF), interstitial lung disease, and acute respiratory distress syndrome isn't easy. But we can get you the patients you need quickly. 

  • Pulmonary function testing, centralized spirometry and fractional exhaled nitric oxide (FeNO)
  • High-resolution computed tomography (HRCT)
  • Measures of exercise capacity, including six-minute walk test (6MWT) and cardiopulmonary exercise testing (CPET)
  • Sputum sampling and processing for biomarker assays, microbiology and cytology
  • Bronchoscopy with bronchoalveolar lavage (BAL)
  • Patient-reported outcomes (ePROs/diaries) and questionnaires
Clinical trials for respiratory and lung disease

Clinical Trials

We've . . . 
  • Supported over 550 immune-mediated inflammatory disease (IMID) clinical trials in the past five years, including more than 90 asthma, 65 COPD, 20 CF and 20 IPF trials.
  • Managed at least 1 IPF trial per year since 2004.
  • Participated in more than 165 studies involving pediatric patients, equating to approximately 20% of all U.S. pediatric trials.

Laboratory Testing

  • Over 90 protocols for asthma and 65 for COPD. 
  • Patients represent the following countries: United States, United Kingdom, Poland, Germany, China, New Zealand, Japan, Russia, Belgium and Ukraine. 
  • To date, we've completed testing in over 50 countries at more than 6,000 sites, representing more than 80,000 patients. 
  • Download our infographic 

•	Total of >175,000 clinical investigators •	Total of >793,000 physicians  •	Total of >15 billion lab test results  •	Total of >16,000 protocols

Clinical knowledgebase housing more than 40% global clinical trial data at any one time 

  • Access more than 150,000 asthma/COPD patients via partnership sites. 
  • Target experienced sites with high recruitment rates using Xcellerate® Trial Design
  • Utilize specialist inflammatory biomarker analysis, e.g. eosinophil cationic protein and periostin
Photo of a group of people standing.
  • Access more than 3,000 asthma and more than 2,500 COPD investigators worldwide
  • Select the highest-ranking investigators using our investigator performance database 
Graphic of a group of doctors
  • Partner with a single organization that offers device testing, in vitro diagnostics, clinical trials and inhalation routes of administration. 
  • Work with a global, dedicated inhalation team and facilities. 
photo of a doctor and a patient talking
  • Centralized objective endpoint analysis to reduce variability
  • Ensuring availability of appropriate instrumentation, and providing study-specific training on instrumentation use, and data collection, handling and interpretation
Photo of an xray of lungs
  • Understand how devices patents (i.e. for inhalation devices) are different than pharma patents 
  • Use effective reimbursement strategies and patient follow-up for patients struggling with respiratory and lung disease
Photo of a bar chart
  • Expertise in pediatric protocol design and implementation
  • Identifying and supporting high-performing pediatric investigators
  • Formulating a pediatric development plan and engaging regulatory agency early in development process
  • Understanding patient challenges using voice of patient and/or parent insights, and incorporating into trial design
  • Site infrastructure to support patient and family needs
Photo of a doctor working with a young patient.